Search Results - Marc Feldmann
- Showing 1 - 10 results of 10
-
1
-
2
Cancer immunotherapy in routine cost‐effective cancer care? by Sir Marc Feldmann
Published in EMBO Molecular Medicine (2018-10-01)Get full text
Article -
3
-
4
-
5
Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel g... by Jagdeep Nanchahal, Nicola Kenealy, Sally Hopewell, Amar Rangan, Ruth Knight, Cynthia Srikesavan, Susan Dutton, Sarah Lamb, Marc Feldmann
Published in NIHR Open Research (2022-04-01)Get full text
Article -
6
Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel g... by Jagdeep Nanchahal, Nicola Kenealy, Sally Hopewell, Amar Rangan, Ruth Knight, Cynthia Srikesavan, Susan Dutton, Sarah Lamb, Marc Feldmann
Published in NIHR Open Research (2023-04-01)Get full text
Article -
7
Anti-TNF (adalimumab) injection for the treatment of pain-predominant early-stage frozen shoulder: the Anti-Freaze-Feasibility randomised controlled trial by Amar Rangan, Sarah Lamb, Anne Francis, Alison Evans, Cynthia Srikesavan, Marc Feldmann, Jagdeep Nanchahal, Fema Er, Jane Preece, M Sofia Massa
Published in BMJ Open (2024-05-01)Get full text
Article -
8
Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity by Natalya M. Kogan, Yarden Lavi, Louise M. Topping, Richard. O. Williams, Fiona E. McCann, Zhanna Yekhtin, Marc Feldmann, Ruth Gallily, Raphael Mechoulam
Published in Molecules (2021-09-01)Get full text
Article -
9
Low‐dose TNF augments fracture healing in normal and osteoporotic bone by up‐regulating the innate immune response by James K Chan, Graeme E Glass, Adel Ersek, Andrew Freidin, Garry A Williams, Kate Gowers, Ana I Espirito Santo, Rosemary Jeffery, William R Otto, Richard Poulsom, Marc Feldmann, Sara M Rankin, Nicole J Horwood, Jagdeep Nanchahal
Published in EMBO Molecular Medicine (2015-03-01)Get full text
Article -
10
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial by Jagdeep Nanchahal, Catherine Ball, Dominique Davidson, Lynn Williams, William Sones, Fiona E. McCann, Marisa Cabrita, Jennifer Swettenham, Neil J. Cahoon, Bethan Copsey, E. Anne Francis, Peter C. Taylor, Joanna Black, Vicki S. Barber, Susan Dutton, Marc Feldmann, Sarah E. Lamb
Published in EBioMedicine (2018-07-01)Get full text
Article
